prostate cancer
Showing NaN - NaN of 158
Prostate Cancer Trial in United States (PSMA-PET CT)
Not yet recruiting
- Prostate Cancer
- PSMA-PET CT
-
Los Angeles, California
- +3 more
Jul 6, 2023
Prostate Cancer Trial in United States (drug, device, procedure)
Recruiting
- Prostate Cancer
- Administration of IS-002
- +2 more
-
San Francisco, California
- +3 more
Jul 7, 2023
Prostate Cancer Trial in San Francisco (MyProstateScore 2.0 Results)
Recruiting
- Prostate Cancer
- MyProstateScore 2.0 Results
-
San Francisco, CaliforniaQURE Healthcare
Jun 15, 2023
Prostate Cancer, Renal Cancer, Urethral Cancer Trial in San Francisco (Copper-64 labeled Granzyme B (64Cu-GRIP B), Positron
Not yet recruiting
- Prostate Cancer
- +2 more
- Copper-64 labeled Granzyme B (64Cu-GRIP B)
- Positron Emission Tomography (PET)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 7, 2023
Prostate Cancer, Localized Prostate Carcinoma Trial in San Francisco (Hyperpolarized Bicarbonate (13C), Magnetic Resonance
Not yet recruiting
- Prostate Cancer
- Localized Prostate Carcinoma
- Hyperpolarized Bicarbonate (13C)
- Magnetic Resonance imaging
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 1, 2023
Predicting Cognitive Decline From Androgen Deprivation Therapy
Not yet recruiting
- Prostate Cancer
- Blood-based assay
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Apr 20, 2023
Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco
Not yet recruiting
- Castrate Resistant Prostate Cancer
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 1, 2023
Prostate Cancer Trial in United States (ARN-509 (Phase 1), ARN-509 (Phase 2))
Active, not recruiting
- Prostate Cancer
- ARN-509 (Phase 1)
- ARN-509 (Phase 2)
-
San Diego, California
- +14 more
Jan 17, 2023
Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)
Active, not recruiting
- Prostate Cancer
- Prostatic Neoplasm
- abiraterone acetate in combination with prednisone
-
Homewood, Alabama
- +44 more
Jan 17, 2023
Prostate Cancer Trial in Canada, United States (70.2 Gy 3D-CRT/IMRT, 79.2 Gy 3D-CRT/IMRT)
Completed
- Prostate Cancer
- 70.2 Gy 3D-CRT/IMRT
- 79.2 Gy 3D-CRT/IMRT
-
Long Beach, California
- +85 more
Dec 27, 2022
Failure in Patients Undergoing Radiation Therapy for Localized
Active, not recruiting
- Prostate Cancer
- Radiation Toxicity
- medical chart review
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 9, 2022
Prostate Cancer Trial in United States (TAK-700, Bicalutamide)
Active, not recruiting
- Prostate Cancer
-
Birmingham, Alabama
- +559 more
Dec 5, 2022
Prostate Cancer Trial in Canada, United States (Best Systemic Therapy (BST), Best Systemic Therapy (BST) + Surgery or Radiation
Active, not recruiting
- Prostate Cancer
- Best Systemic Therapy (BST)
- +3 more
-
San Francisco, California
- +3 more
Dec 5, 2022
Prostate Cancer Trial in United States (abiraterone acetate, Prednisone)
Active, not recruiting
- Prostate Cancer
- abiraterone acetate
- Prednisone
-
Jonesboro, Arkansas
- +204 more
Nov 30, 2022
Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Trial in United States (Darolutamide, Enzalutamide)
Recruiting
- Metastatic Prostate Cancer
- +3 more
-
San Diego, California
- +11 more
Nov 28, 2022
Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T
Active, not recruiting
- Prostatic Neoplasms, Castration-Resistant
- +16 more
- P-PSMA-101 CAR-T cells
- Rimiducid
-
Duarte, California
- +9 more
Nov 15, 2022
Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or
Active, not recruiting
- Melanoma
- +8 more
- Pegilodecakin
- +9 more
-
Los Angeles, California
- +9 more
Nov 15, 2022
Prostate Cancer Trial in San Francisco (Prostatic artery embolization)
Not yet recruiting
- Prostate Cancer
- Prostatic artery embolization
-
San Francisco, CaliforniaStanford Cancer Center
Nov 9, 2022
Prostate Cancer Trial in San Francisco (STAND-T platform, Survey Administration, Text Messages)
Recruiting
- Prostate Cancer
- STAND-T platform
- +2 more
-
San Francisco, California
- +1 more
Oct 26, 2022
Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer Trial in San Francisco, Saint Louis (Atezolizumab,
Recruiting
- Prostate Adenocarcinoma
- +2 more
- Atezolizumab
- +2 more
-
San Francisco, California
- +1 more
Oct 8, 2022
Prostate Adenocarcinoma, Prostate Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance
Recruiting
- Prostate Adenocarcinoma
- Prostate Cancer
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 3, 2022